GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
T45.1X5A
Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
ICD10CM code
Medical Policies and Guidelines for Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
Related policies from health plans
ANTHEM-BLUECROSS-CA
Genotype Testing for Individual Genetic Polymorphisms to Determine Drug-Metabolizer
ANTHEM-BLUECROSS-CA
Selected Injectable 5HT3 Antiemetic Agents
ANTHEM-BLUECROSS-CT
CG-GENE-11 Genotype Testing for Individual Genetic Polymorphisms to Determine Drug-Metabolizer Status
OSCAR
Pedmark (sodium thiosulfate) (PG133)
OSCAR
Varubi (rolapitant) (PG178)
CIGNA
Transthoracic Echocardiography in Adults - (0510)
CIGNA
Transthoracic Echocardiography in Adults - (0510)
CIGNA
Transthoracic Echocardiography in Children - (0523)
Similar Codes
ICD10CM codes
T45.1X5A
- Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
T45.1X5D
- Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter
T45.1X5
- Adverse effect of antineoplastic and immunosuppressive drugs
T45.1X5S
- Adverse effect of antineoplastic and immunosuppressive drugs, sequela
T45.1X6A
- Underdosing of antineoplastic and immunosuppressive drugs, initial encounter
T45.1X4A
- Poisoning by antineoplastic and immunosuppressive drugs, undetermined, initial encounter
T45.1X1A
- Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encount
T45.8X5A
- Adverse effect of other primarily systemic and hematological agents, initial encounter
T45.1X6D
- Underdosing of antineoplastic and immunosuppressive drugs, subsequent encounter
T45.1X3A
- Poisoning by antineoplastic and immunosuppressive drugs, assault, initial encounter
HCPCS codes
J7599
- Immunosuppressive drug, not otherwise classified
J9999
- Not otherwise classified, antineoplastic drugs
Q0510
- Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant
G8927
- Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer
J9055
- Injection, cetuximab, 10 mg
S9359
- Home infusion therapy, anti-tumor necrosis factor intravenous therapy; (e.g., infliximab); administr
G9842
- Patient has metastatic disease at diagnosis
J9000
- Injection, doxorubicin hydrochloride, 10 mg
D9610
- THERAPEUTIC PARENTERAL DRUG
Q2050
- Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg
CPT4 codes
96402
- Chemotherapy administration, subcutaneous or intramuscular; hormonal anti-neoplastic
96401
- Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic
96549
- Unlisted chemotherapy procedure
96409
- Chemotherapy administration; intravenous, push technique, single or initial substance/drug
96405
- Chemotherapy administration; intralesional, up to and including 7 lesions
96406
- Chemotherapy administration; intralesional, more than 7 lesions
80193
- Leflunomide
96411
- Chemotherapy administration; intravenous, push technique, each additional substance/drug (List separ
4037F
- Influenza immunization ordered or administered (COPD, PV, CKD, ESRD)(IBD)
88239
- Tissue culture for neoplastic disorders; solid tumor